Metastasis and Chest pain
Summary:
Chest pain is found among people with Metastasis, especially for people who are male, 60+ old.
The study analyzes which people have Chest pain with Metastasis. It is created by eHealthMe based on reports of 58 people who have Metastasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Metastasis?
Metastasis (spreadable cancer to other organ from origin) is found to be associated with 537 drugs and 841 conditions by eHealthMe. Check the latest studies of Metastasis.
What is Chest pain?
Chest pain is found to be associated with 3,460 drugs and 4,888 conditions by eHealthMe. Check the latest studies of Chest pain.
58 people who have Metastasis and Chest Pain are studied.

Gender of people who have Metastasis and experienced Chest Pain *:
- female: 45.61 %
- male: 54.39 %
Age of people who have Metastasis and experienced Chest Pain *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 4.55 %
- 30-39: 4.55 %
- 40-49: 4.55 %
- 50-59: 20.45 %
- 60+: 65.91 %
Common co-existing conditions for these people *:
- High Blood Pressure: 13 people, 22.41%
- Abdominal Discomfort: 5 people, 8.62%
- Metastases To Liver (cancer spreads to liver): 5 people, 8.62%
- Carcinoid Tumor Of The Small Bowel: 5 people, 8.62%
- Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 5 people, 8.62%
- Renal Cell Carcinoma (a kidney cancer): 4 people, 6.90%
- Breast Cancer: 4 people, 6.90%
- Pain: 3 people, 5.17%
- Malignant Melanoma (skin cancer rises from melancytes): 3 people, 5.17%
- Metastases To Lung (cancer spreads to lung): 2 people, 3.45%
Common drugs taken by these people *:
- Hydrochlorothiazide: 10 people, 17.24%
- Zometa: 10 people, 17.24%
- Levaquin: 9 people, 15.52%
- Lopressor: 9 people, 15.52%
- Prevacid: 9 people, 15.52%
- Cloderm: 8 people, 13.79%
- Casodex: 8 people, 13.79%
- Nasacort: 8 people, 13.79%
- Lupron: 8 people, 13.79%
- Ofloxacin: 8 people, 13.79%
Common symptoms for these people *:
- Dyspnea (difficult or laboured breathing): 19 people, 32.76%
- Constipation: 17 people, 29.31%
- Back Pain: 16 people, 27.59%
- High Blood Pressure: 15 people, 25.86%
- Diarrhea: 15 people, 25.86%
- Anaemia (lack of blood): 12 people, 20.69%
- Pain: 12 people, 20.69%
- Hypoaesthesia (reduced sense of touch or sensation): 11 people, 18.97%
- Pain In Jaw: 11 people, 18.97%
- Joint Pain: 11 people, 18.97%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Chest pain?
- Check whether Chest pain is associated with a drug or a conditionRelated publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Metastasis (11,222 reports)
- Chest pain (363,501 reports)
All the drugs that are associated with Chest pain:
- Chest pain (3,460 drugs)
All the conditions that are associated with Chest pain:
- Chest pain (4,888 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Chest pain and Metastasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Apremilast and Hair Thinning for Men aged 40-49 - 24 seconds ago
- Apremilast and Loss Of Hair for Men aged 40-49 - 25 seconds ago
- Apremilast and Hairloss for Men aged 40-49 - 25 seconds ago
- Apremilast and Baldness for Men aged 40-49 - 25 seconds ago
- Apremilast and Alopecia for Men aged 40-49 - 26 seconds ago
- Apremilast and Hair Loss for Men aged 40-49 - 26 seconds ago
- Could Megace cause Toothaches? - 27 seconds ago
- Could Betaseron cause Breathing - Slowed Or Stopped? - 42 seconds ago
- Polyethylene Glycol 3350 and Pain Exacerbated for Women aged 50-59 - 48 seconds ago
- Could Acetaminophen, Aspirin And Caffeine cause Weakness? - 50 seconds ago